Medthority

Less than one month to go! Register now to join Dr Stephen Ansell and expert colleagues for a live, virtual, EBAC-accredited roundtable on . Earn 1 CME point and get your questions answered on applying the latest frontline strategies in lymphoma treatment. 14 October 2024 – 15:00–16:00 UTC

https://ow.ly/sp7T50TpXHq

kicks off in Copenhagen this week! Are you there? Register with Medthority to keep up to date with clinical guidelines, the latest patient-centred treatment approaches, and tools to assess disease progression

https://ow.ly/traB50TpWZY

Did you miss ? Get up to date on the headline topics, with this short article from our Head of Science, Ben Gallarda, PhD.

Includes key points from Dr Lynn M Schuchter’s opening talk, the application of AI in oncology research and care, and key priorities for the National Cancer Institute

https://ow.ly/igQC50TkYeU

It’s World AF Awareness Day! Access free, expert resources for the latest thinking on managing atrial fibrillation (AF) and stroke prevention, including our evaluation of real-world research on non-vitamin K antagonist oral anticoagulants for AF

https://ow.ly/txla50TkXYn

Find out about the latest research investigating exercise as a low-cost, accessible intervention for reducing the risk of Parkinson’s disease, and even treating symptoms, with our new Spotlight article

https://ow.ly/V0NZ50TkXL2

Do you consider modifiable bleeding risk factors and follow up after initiating direct oral anticoagulants (DOAC) in patients with ? Don’t miss this review of a study presented at by Jordan Schaefer investigating bleeding risk, including takeaways for clinical practice

https://ow.ly/fHvN50TkXmj

starts today! Access expert resources on weight management in type 2 diabetes, covering lifestyle factors, pharmacological strategies and tips for communicating with patients. Free for healthcare professionals on Medthority

https://www.medthority.com/medical-education/weight-control-in-type-2-diabetes/weight-management-in-t2d/ -is-essential

Molecularly targeted therapies for lymphoma: what key data and future directions were presented at and ? Watch expert insights presented by Professor Wojciech Jurczak, plus other highlights from this year’s major congresses

https://ow.ly/SKtG50T8ECY

Watch the latest updates in hidradenitis suppurativa (HS) from , with expert presentations from Dr Antonio Martorell, Dr Philippe Guillem, and Prof. Falk Bechara. Find out more about treatments, disease management, and pathophysiology

https://ow.ly/Cava50T8Egq

How much do you know about minimising the accrual of irreversible organ damage in people with lupus? Get expert insights from Professors Antonis Fanouriakis, Hans-Joachim Anders and Edith Williams with our EACCME accredited webinar, and earn 1 CME point

https://www.medthority.com/medical-education/lupus-learning-zone/eaccme-accredited-webinar/?utm_source=facebook&utm_medium=organic%20social&utm_campaign=222 #

What language can healthcare providers use when tackling the subject of weight management with type 2 diabetes (T2D) patients? Listen to experts Professors Melanie Davies and Rachel Batterham as they discuss this hot topic in an ACCME-accredited podcast series. Earn 1 CME point!

https://ow.ly/5Bvb50T8ABI

Find out more about the current treatment landscape for growth hormone deficiency (GHD), including the results of a Phase 3 study investigating the efficacy and safety of long-acting growth hormone (LAGH) versus daily growth hormone

https://ow.ly/ft5B50T20he

Which treatment goals and targets have the most impact for people with ulcerative colitis (UC)? Get expert guidance from Dr Tim Raine on incorporating the latest therapeutic approaches into your practice

https://ow.ly/8l7c50T1ZWl

From novel therapies to patient-centred approaches, find out more about the latest advances in care for metastatic castration-resistant prostate cancer (mCRPC), with Profs. Axel Merseburger and Neeraj Agarwal

https://ow.ly/fjnn50T1ZyN

What are effective treatment options for hidradenitis suppurativa (HS)? Access the latest information, including medical and surgical treatments as part of a treat-to-target approach, in our comprehensive HS Learning Zone

https://ow.ly/RxiN50T1Z5K

Join Drs Stephen Ansell, Pier Luigi Zinzani, and John Kuruvilla for a live, virtual roundtable on the most impactful data presented at , and . Get your questions answered about the latest lymphoma treatment strategies in practice.

14 October 2024, 15:00–16:00 UTC

https://ow.ly/M49W50SWQ7M

Leading lymphoma: Expert insights Join Drs Ansell, Zinzani, and Kuruvilla for a lymphoma roundtable on Oct 14 discussing advances and breaking congress data from ASCO and EHA2024.

A smartwatch has detected signs of moderate-to-severe obstructive sleep apnea (OSA) in adults without a prior diagnosis. But how does the data compare with that obtained from polysomnography? And could it lead to earlier detection of undiagnosed OSA? Find out more on Medthority.

https://ow.ly/XqGO50SWPsT

Can smartwatches detect sleep apnea earlier? How does Samsung’s sleep apnea feature work, how accurate is it, and could it facilitate earlier detection of undiagnosed OSA? Find out more.

How does telehealth-based palliative care impact quality of life for people with advanced non-small cell lung cancer (NSCLC), compared with in-person care? Read our latest article on new outcome data presented at , including results and next steps.

https://ow.ly/j1hZ50SWPeq

From real-world safety profiles to genomic crystal balls, here’s what you need to know from . Find out more about the latest advances in early breast cancer treatment and innovative approaches for metastatic and triple-negative breast cancers on Medthority.

https://ow.ly/kXRi50SVNCj

What are the clinical barriers to uptake of clinical practice guidelines for mCRPC? Watch expert interview with Profs. Axel Merseburger and Neeraj Agarwal on key topics in mCRPC management

https://ow.ly/jVEh50SSSMY

Did you know? Once you have read all four articles in our series on menopause-related vasomotor symptoms (VMS), you can unlock exclusive content. Don’t miss expert interviews with Drs Jewel Kling, Lisa Larkin and Sheryl Kingsberg, including a closer look at the psychological implications of VMS.

https://ow.ly/KXs550SP0LY

How do you select the right biologic to optimise outcomes in plaque psoriasis? This , watch our expert roundtable discussion, chaired by Professor Luis Puig, including insights on switching and combining therapies. Available on demand.

https://ow.ly/wGuz50SOZJR

What investigational treatments are in clinical development to help address unmet needs for moderate-to-severe ulcerative colitis? Access clinical guidelines and treatment information on Medthority.

https://ow.ly/QN2x50SK50V

How do the costs of growth hormone deficiency (GHD) treatment differ across the globe? Read about the health economics of GHD care, plus an overview of approved treatments and related safety data.

https://ow.ly/qOhx50SK4xA

What progress has been made in risk assessment for venous thromboembolism in cancer patients? Unlock real-world evidence presented at on Medthority.

https://ow.ly/t5TI50SK4eh

“We are living in a world where there will always be more than one possibility to get the patients through.” Watch Prof. Wojciech Jurczak present research highlights from and , and the implications for the future of treatment.

https://ow.ly/jxiv50SK3N1

From MS to migraine, uncover the latest insights this . If you're a healthcare professional working in , don't miss free, expert learning resources for your specialty on Medthority.

https://ow.ly/5pKN50SBwT3

What potential does RNA interference hold for the future of alpha-1 antitrypsin deficiency (AATD) treatment? Professor Pavel Strnad and Dr Thomas Schluep discuss this new treatment option so you can learn more for free on Medthority.

https://ow.ly/cSOv50SBwEW

Get free access to key highlights on including treatment advances, innovative biomarker-adapted strategies and new therapies direct from and on Medthority now.

https://ow.ly/NUGU50SBvFO

Want to know more about innovative approaches to treating breast cancers, including metastatic and triple-negative variants? Sign up on Medthority now for free access to expert coverage of .

https://ow.ly/Okgo50SBv9j